A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1992
12/10/1992	WO1992021699A1 Biocidal proteins
12/10/1992	WO1992021696A1 Hydroxyazido derivatives and related compounds as renin inhibitors
12/10/1992	WO1992021695A1 Vitamin d derivatives comprising a lateral chain expoxide group
12/10/1992	WO1992021676A1 Crystalline oxathiolane derivatives
12/10/1992	WO1992021648A1 Amino acid derivative anticonvulsant
12/10/1992	WO1992021402A1 Method for improving autologous transplantation
12/10/1992	WO1992021380A1 Method to treat kaposi's sarcoma
12/10/1992	WO1992021379A1 Radiolabeled metal-binding protein for the treatment of arthritis
12/10/1992	WO1992021370A1 Fish vaccine for aeromonas salmonicida infection
12/10/1992	WO1992021368A1 Composition and method for disease treatment
12/10/1992	WO1992021367A1 T cell receptor peptides as therapeutics for immune-related disease
12/10/1992	WO1992021365A1 Therapeutic compositions for osteoinduction
12/10/1992	WO1992021364A1 Cea-binding proteins and methods for their isolation and use
12/10/1992	WO1992021363A1 Inhibition of smooth muscle cell proliferation by vitronectin
12/10/1992	WO1992021362A1 Nerve growth factor for use in the prevention and treatment of viral infections
12/10/1992	WO1992021361A1 Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands
12/10/1992	WO1992021360A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
12/10/1992	WO1992021355A1 Calcium, trace mineral, vitamin d and drug therapy combinations
12/10/1992	WO1992021354A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
12/10/1992	WO1992021327A1 Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same
12/10/1992	WO1992021321A1 Method for separating a vegetable compound
12/10/1992	WO1992021320A1 Disinfecting shampoo composition for animals
12/10/1992	WO1992021240A1 Suppressor t-cell hybridoma
12/10/1992	WO1992019244A3 A method for treating infectious respiratory diseases
12/10/1992	WO1992017445A3 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
12/10/1992	WO1992017184A3 Bioactive topical siloxane compositions having enhanced performance and safety
12/10/1992	WO1992017025A3 GnRH analogs
12/10/1992	WO1992013878A3 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
12/10/1992	WO1992013078A3 Pasteurella haemolytica glycoprotease gene and the purified enzyme
12/10/1992	WO1992012996A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
12/10/1992	CA2110690A1 Fish vaccine for aeromonas salmonicida infection
12/10/1992	CA2110404A1 Human lactoferrin
12/10/1992	CA2110403A1 Biocidal proteins
12/10/1992	CA2110389A1 Mycobacterium proteins and applications
12/10/1992	CA2110381A1 Hydroxyazido derivatives and related compounds as renin inhibitors
12/10/1992	CA2110292A1 Device and method for the analysis of rolling blood leukocytes and identifying inhibitors and promoters
12/10/1992	CA2110158A1 Vitamin d derivatives comprising a lateral chain expoxide group
12/10/1992	CA2109707A1 Vegetal coumpound extraction process
12/10/1992	CA2109699A1 Method for improving autologous transplantation
12/10/1992	CA2103046A1 Suppressor t-cell hybridoma
12/10/1992	CA2102890A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
12/09/1992	EP0517589A2 Tachykinin derivatives, their preparation and pharmaceutical compositions containing them
12/09/1992	EP0517565A2 Process for the preparation of microspheres containing biologically active components
12/09/1992	EP0517484A2 Fermentation analogs of virginiamycin M1
12/09/1992	EP0517464A1 Peptides useful in regulating the immune and nervous systems
12/09/1992	EP0517345A1 Intermediates of the mureidomycin group, their preparation, and their use
12/09/1992	EP0517211A1 Physiologically active polypeptide containing pharmaceutical composition
12/09/1992	EP0517182A1 Hepatocyte-growth agent
12/09/1992	EP0517174A2 LFA-3 protein and derivatives
12/09/1992	EP0517145A1 Crystalline oxathiolane derivatives
12/09/1992	EP0517126A1 Use of diacetyl-splenopentin in chemotherapy and radiation therapy
12/09/1992	EP0517024A2 Tetravalent bispecific receptors, their preparation and use
12/09/1992	EP0516953A1 Conjugates of liposomes or micro-beads and antibodies specific for T lymphocytes
12/09/1992	EP0516901A1 Method and apparatus of a serumfree medical solution
12/09/1992	EP0516859A1 Non-a non-b hepatitis virus antigen protein
12/09/1992	EP0516851A1 Physiologically active substance well capable of permeating biomembrane
12/09/1992	EP0516845A1 Novel megakaryocytic colony stimulating factor and process for its preparation
12/09/1992	EP0516747A1 COMPOSITIONS AND METHODS FOR TREATING INFECTIONS CAUSED BY ORGANISMS SENSITIVE TO $g(b)-LACTAM ANTIBIOTICS
12/09/1992	EP0516704A1 Novel insulin compositions.
12/09/1992	EP0516685A1 Artificial tears
12/09/1992	CN1066790A Non-porous collagen sheet for therapeutic use, and method and apparatus for preparing it
12/09/1992	CN1019355B Process for minactivin and its use
12/08/1992	US5169934 Intracellularly cleavable compounds
12/08/1992	US5169932 Hormone inhibitors, antitumor agents
12/08/1992	US5169930 Integrin with preferential binding to fibronectin not vitronectin
12/08/1992	US5169865 Bioactive, amphiphilic conformation of hormones, neurotransmitters, calcium channel blockers by binding with calcium and magnesium ions
12/08/1992	US5169862 Bactericides, viricides, antiprotozoa agents
12/08/1992	US5169841 Enzyme inhibitors, hypotensive agents, high enteral bioauailability
12/08/1992	US5169840 Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation
12/08/1992	US5169837 Isolated osteogenic factor
12/08/1992	US5169836 Inhibitors of platelet binding
12/08/1992	US5169835 Pregancy specific proteins applications
12/08/1992	US5169834 Compositions and method for reducing vial breakage during lyophilization
12/08/1992	US5169833 Analgesics
12/08/1992	US5169775 React with canin lympohma cells and not with normal canine lymphocytes
12/08/1992	US5169774 Monoclonal anti-human breast cancer antibodies
12/08/1992	US5169765 Method for stimulating production of bone marrow cell growth factors using dithiocarbamates
12/08/1992	US5169764 Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
12/08/1992	US5169763 Contains promoter for expressing non-cleavable dna fragments with signal peptide in mammalian cells
12/08/1992	US5169762 Transforming Escherichia coli host cell with replicable expression vector which expresses isolated DNA sequence encoding human nerve growth factor polypeptide
12/08/1992	US5169761 Dna encoding and expression systems for alveolar surfactant proteins
12/08/1992	US5169752 Methods and materials for HIV detection
12/08/1992	US5169630 Containing superoxide dismutase
12/07/1992	WO1992021759A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof
12/07/1992	CA2088666A1 Nucleotide and peptide sequences of hepatitis c virus isolate, diagnostic and therapeutic applications
12/06/1992	WO1992021369A1 Synthetic calcitonin peptides
12/06/1992	CA2088922A1 Synthetic calcitonin peptides
12/05/1992	CA2070331A1 Tachykinin denved peptides and pseudopeptides, process for their preparation and pharmaceutical compositions containing them
12/04/1992	WO1992021383A1 Radiolabelled somatostatin derivatives, their preparation and use
12/04/1992	WO1992021373A1 USE OF CANPs-INHIBITORS IN PHARMACEUTICAL PREPARATIONS
12/04/1992	WO1992021366A1 Immunoregulatory and neuroregulatory pentapeptides
12/04/1992	CA2102633A1 Radiolabelled somatostatin derivatives, their preparation and use
12/04/1992	CA2088664A1 Immunoregulatory and neuroregulatory pentapeptides
12/04/1992	CA2070263A1 Hepatocyte-growth agent
12/04/1992	CA2070242A1 Fermentation analogs of virginiamycin m1
12/04/1992	CA2070233A1 Tetravalent bispecific receptors, the preparation and use thereof
12/03/1992	DE4117733A1 Cyclo-peptide(s) agonists to atrial natriuretic protein
12/02/1992	EP0516450A2 CRF analogs
12/02/1992	EP0516278A1 Use of anti-mullerian hormone for reversal of female sexual phenotype in poultry
12/02/1992	EP0516190A2 Monoclonal antibodies, process for preparing them and their use

1 ... 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 ... 3163